Shuang Li

This inventor holds 1 USPTO granted patent. Top assignee: Recode Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuang Li. Retrieved from https://idiyas.com/inventor/shuang-li-5cajsk0v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuang Li: Innovator in Lipid Nanoparticle Technologies

Introduction

Shuang Li is a notable inventor recognized for his contributions to the field of lipid nanoparticle compositions. His innovative work has led to the development of significant technologies that have potential applications in various medical fields.

Latest Patents

Shuang Li holds a patent for "Lipid Nanoparticle Compositions and Uses Thereof." This patent highlights his expertise in creating formulations that can enhance the delivery of therapeutic agents, showcasing his commitment to advancing medical science. He has 1 patent to his name, reflecting his innovative contributions to the industry.

Career Highlights

Currently, Shuang Li is employed at Recode Therapeutics, Inc., where he continues to push the boundaries of research and development in lipid nanoparticle technologies. His work at this company is pivotal in exploring new therapeutic avenues and improving patient outcomes.

Collaborations

Shuang Li collaborates with talented professionals in his field, including Mirko Hennig and Ali Ahmed Alfaifi. These partnerships enhance the research environment and foster innovation, leading to groundbreaking advancements in their respective areas of expertise.

Conclusion

Shuang Li's work in lipid nanoparticle compositions exemplifies the spirit of innovation in the medical field. His contributions are paving the way for future advancements that could significantly impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…